How are Gemfibrozil adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Gemfibrozil, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Gemfibrozil is flagged as the suspect drug causing the adverse event.
What are the most common Gemfibrozil adverse events reported to the FDA?
Rhabdomyolysis | 248 (7.68%) |
Renal Failure Acute | 122 (3.78%) |
Myalgia | 96 (2.97%) |
Drug Interaction | 93 (2.88%) |
Completed Suicide | 78 (2.41%) |
Blood Creatine Phosphokinase Increa... | 75 (2.32%) |
Asthenia | 71 (2.2%) |
Nausea | 47 (1.45%) |
Blood Creatinine Increased | 34 (1.05%) |
Muscular Weakness | 34 (1.05%) |
Aspartate Aminotransferase Increase... | 33 (1.02%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Gemfibrozil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Gemfibrozil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Gemfibrozil adverse events reported to the FDA?
Muscle | 459 (14.21%) |
Renal Disorders | 177 (5.48%) |
Gastrointestinal Signs | 146 (4.52%) |
Neurological | 130 (4.02%) |
Hepatobiliary | 120 (3.71%) |
Therapeutic And Nontherapeutic Effe... | 118 (3.65%) |
Enzyme | 93 (2.88%) |
Suicidal And Self-injurious Behavio... | 87 (2.69%) |
Medication Errors | 72 (2.23%) |
Respiratory | 68 (2.1%) |
Cardiac Arrhythmias | 67 (2.07%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Gemfibrozil, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Gemfibrozil is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Gemfibrozil, according to those reporting adverse events to the FDA?
Hyperlipidaemia | 270 |
Blood Cholesterol Increased | 231 |
Product Used For Unknown Indication | 229 |
Drug Use For Unknown Indication | 201 |
Blood Cholesterol | 144 |
Blood Triglycerides Increased | 137 |
Show More |
Label | Labeler | Effective |
---|---|---|
Gemfibrozil | Physicians Total Care, Inc. | 26-JAN-10 |
Gemfibrozil | KAISER FOUNDATION HOSPITALS | 25-FEB-10 |
Gemfibrozil | KAISER FOUNDATION HOSPITALS | 01-MAR-10 |
Gemfibrozil | Contract Pharmacy Services-PA | 05-APR-10 |
Gemfibrozil | Bryant Ranch Prepack | 10-MAY-10 |
Gemfibrozil | State of Florida DOH Central Pharmacy | 02-JUN-10 |
Gemfibrozil | Global Pharmaceuticals, Division of Impax Laboratories Inc. | 02-JUN-10 |
Gemfibrozil | State of Florida DOH Central Pharmacy | 02-JUN-10 |
Gemfibrozil | Major Pharmaceuticals | 26-JUL-10 |
Gemfibrozil | State of Florida DOH Central Pharmacy | 27-AUG-10 |
Lopid | Parke-Davis Div of Pfizer Inc | 06-OCT-10 |
Gemfibrozil | Hikma Pharmaceutical | 03-NOV-10 |
Gemfibrozil | West-ward Pharmaceutical Corp | 03-NOV-10 |
Gemfibrozil | Contract Pharmacy Services-PA | 03-NOV-10 |
Gemfibrozil | PD-Rx Pharmaceuticals, Inc. | 01-DEC-10 |
Gemfibrozil | DAVA Pharmaceuticals, Inc. | 01-DEC-10 |
Gemfibrozil | Apotex Corp. | 17-FEB-11 |
Gemfibrozil | Rebel Distributors Corp | 08-MAR-11 |
Gemfibrozil | Blu Pharmaceuticals, LLC | 26-APR-11 |
Gemfibrozil | Cardinal Health | 10-MAY-11 |
Gemfibrozil | REMEDYREPACK INC. | 09-JUN-11 |
Gemfibrozil | UDL Laboratories, Inc. | 10-JUN-11 |
Gemfibrozil | REMEDYREPACK INC. | 22-JUN-11 |
Gemfibrozil | Golden State Medical Supply, Inc. | 01-JUL-11 |
Gemfibrozil | Golden State Medical Supply, Inc. | 01-JUL-11 |
Gemfibrozil | Med-Health Pharma, LLC | 04-JUL-11 |
Gemfibrozil | REMEDYREPACK INC. | 19-JUL-11 |
Gemfibrozil | Camber Pharmaceuticals | 18-AUG-11 |
Gemfibrozil | Preferred Pharmaceuticals, Inc | 18-AUG-11 |
Gemfibrozil | Exelan Pharmaceuticals, Inc. | 29-SEP-11 |
Gemfibrozil | Cardinal Health | 25-OCT-11 |
Gemfibrozil | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. | 27-OCT-11 |
Gemfibrozil | McKesson Contract Packaging | 11-NOV-11 |
Gemfibrozil | American Health Packaging | 05-DEC-11 |
Gemfibrozil | Caraco Pharmaceutical Laboratories, Ltd. | 05-JAN-12 |
Gemfibrozil | West-ward Pharmaceutical Corp | 10-JAN-12 |
Gemfibrozil | Aphena Pharma Solutions - Tennessee, Inc. | 29-MAR-12 |
Gemfibrozil | Teva Pharmaceuticals USA Inc | 14-AUG-12 |
Gemfibrozil | REMEDYREPACK INC. | 21-SEP-12 |
Gemfibrozil | Major Pharmaceuticals | 21-SEP-12 |
Gemfibrozil | Dispensing Solutions, Inc. | 28-SEP-12 |
Gemfibrozil | Northstar RxLLC | 15-JAN-13 |
Gemfibrozil | NCS HealthCare of KY, Inc dba Vangard Labs | 13-FEB-13 |
What Gemfibrozil safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Gemfibrozil. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Gemfibrozil.